Hilmar Bischoff
Impact in
-
- Natural Antidiabetic Agents Studies
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
- Surgery 14
- Lipoproteins and Cardiovascular Health 8
- Pancreatitis Pathology and Treatment 4
-
- Plant biochemistry and biosynthesis 5
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- Virginie Nahoum (4 shared papers)F. Payan (4 shared papers)Antoine Puigserver (3 shared papers)Pierre Rougé (3 shared papers)Geneviève Roux (3 shared papers)Bernard Henrissat (3 shared papers)Rolf Angerbauer (4 shared papers)Delf Schmidt (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Atherosclerosis (4 papers)Biochemical Journal (2 papers)Cardiovascular Drug Reviews (1 paper)Structure (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Hilmar Bischoff
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 413
- Biochemistry 135
- Biotechnology 192
- Pharmacology 85
- Organic Chemistry 258
Countries citing papers authored by Hilmar Bischoff
This map shows the geographic impact of Hilmar Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilmar Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilmar Bischoff more than expected).
Fields of papers citing papers by Hilmar Bischoff
This network shows the impact of papers produced by Hilmar Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilmar Bischoff. The network helps show where Hilmar Bischoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Hilmar Bischoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacology of alpha-glucosidase inhibition. | 1994 | 219 |
| 2 | The mechanism of alpha-glucosidase inhibition in the management of diabetes. | 1995 | 194 |
| 3 | 2000 | 104 | |
| 4 | 1997 | 94 | |
| 5 | Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors. | 2000 | 85 |
| 6 | 2001 | 69 | |
| 7 | 1997 | 66 | |
| 8 | 2005 | 57 | |
| 9 | 1999 | 36 | |
| 10 | 1998 | 31 | |
| 11 | 2010 | 26 | |
| 12 | 2005 | 25 | |
| 13 | 1994 | 25 | |
| 14 | 1997 | 24 | |
| 15 | 2000 | 22 | |
| 16 | 1994 | 20 | |
| 17 | 2010 | 19 | |
| 18 | 2004 | 19 | |
| 19 | 2010 | 17 | |
| 20 | 1998 | 17 |
About Hilmar Bischoff
Hilmar Bischoff is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Biotechnology and Computational Theory and Mathematics, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Computational Drug Discovery Methods (6 papers), Natural Antidiabetic Agents Studies (5 papers), Plant biochemistry and biosynthesis (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Pancreatitis Pathology and Treatment (4 papers), Enzyme Production and Characterization (4 papers) and Microbial Metabolism and Applications (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (413 citations), Biochemistry (135 citations), Biotechnology (192 citations), Pharmacology (85 citations) and Organic Chemistry (258 citations). Hilmar Bischoff has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Virginie Nahoum, F. Payan, Antoine Puigserver, Pierre Rougé, Geneviève Roux, Bernard Henrissat, Rolf Angerbauer, Delf Schmidt, Allen H. Heller and Véronique Le Berre. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Atherosclerosis, Biochemical Journal, Cardiovascular Drug Reviews and Structure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.